Mira Pharmaceuticals MIRA
NASDAQ MIRA
$0.63 -0.05 (-7.76%)
As of: Oct 22, 2026 · 3:59 PM EDT

Mira Pharmaceuticals (MIRA) Operating Leases (2022 - 2023)

Updated

Mira Pharmaceuticals' Operating Leases was $34,528 in the quarter ended Sep 30, 2023, down 32.9% from the prior quarter.

Analysis

Mira Pharmaceuticals (MIRA) Operating Leases (2022 - 2023) Analysis & Trends

As of Dec 31, 2022, Operating Leases at Mira Pharmaceuticals came in at $84,267.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Mira Pharmaceuticals 14.90 Mn -5.60 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 34,528.00
Jun 30, 2023 51,472.00
Dec 31, 2022 84,267.00
API Access

Mira Pharmaceuticals Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=MIRA&period=max&api_key=YOUR_API_KEY